TRVI icon

Trevi Therapeutics

40 hedge funds and large institutions have $70.5M invested in Trevi Therapeutics in 2022 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 14 increasing their positions, 10 reducing their positions, and 3 closing their positions.

Holders
40
Holders Change
+8
Holders Change %
+25%
% of All Funds
0.69%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
11
Increased
14
Reduced
10
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
JF
26
Jump Financial
Illinois
$66K +$66K +42,977 New
Millennium Management
27
Millennium Management
New York
$62K -$40.7K -26,222 -40%
Northern Trust
28
Northern Trust
Illinois
$61K -$9.73K -6,371 -14%
ACP
29
Acuta Capital Partners
California
$56K +$2.01K +1,302 +4%
UBV
30
United Bank (Virginia)
Virginia
$44K
LPL Financial
31
LPL Financial
California
$31K +$15.5K +10,000 +100%
Bank of New York Mellon
32
Bank of New York Mellon
New York
$22K +$22K +14,098 New
Charles Schwab
33
Charles Schwab
California
$20K
CS
34
Credit Suisse
Switzerland
$16K +$16K +10,374 New
TRCT
35
Tower Research Capital (TRC)
New York
$15K +$9.06K +5,912 +153%
UBS Group
36
UBS Group
Switzerland
$7K -$809 -494 -10%
First Manhattan
37
First Manhattan
New York
$2K -$1.33K -1,000 -40%
Federated Hermes
38
Federated Hermes
Pennsylvania
$1K +$1K +872 New
FIA
39
FNY Investment Advisers
New York
-$22K -7,986 Closed
Citigroup
40
Citigroup
New York
-$5K -1,700 Closed
CWM
41
Curi Wealth Management
North Carolina
-$3K -998 Closed